In this May 30, 2013, file photo, "Companion Cannabis: Medical Marijuana for Dogs & Cats" by Holistic Therapeutics is displayed at La Brea Compassionate Caregivers, a medical marijuana dispensary in Los Angeles. (AP Photo/Damian Dovarganes, File)

CARSON CITY, Nev. (AP) — Pets might soon be able to use pot under a bill introduced Tuesday in the Nevada Legislature.

Democratic Sen. Tick Segerblom is sponsoring the measure that would allow animal owners to get marijuana for their pet if a veterinarian certifies the animal has an illness that might be alleviated by the drug.

Segerblom said he’s concerned that some animals might have adverse reactions, but “you don’t know until you try,” he said.

A local group is hoping to gain support to include Guam in federal legislation that would allow medical marijuana to be used in states where it's legal at the local level.

On March 10, Sens. Rand Paul, R-Ky., Cory Booker, D-N.J., and Kirsten Gillibrand, D-N.Y., announced bipartisan legislation that would allow the use of medical marijuana in states where it's legal without fear of federal prosecution, a release from Paul's office states.

The Compassionate Access, Research Expansion and Respect States (CARERS) Act would reschedule marijuana from a Schedule I to Schedule II drug to recognize its medical use, and would amend federal law to allow states to set their own medical marijuana policies, the release states.

The Internal Revenue Service has backed away from a policy that penalized an unbanked marijuana business in Denver for paying taxes in cash, but the federal agency will not say if the approach applies industry-wide.

In a settlement with Denver-based Allgreens, a medical-marijuana dispensary that challenged the agency over its policy, the IRS said it would abate future penalties and will refund about $25,000 of fines the business was forced to pay despite having paid its federal employment withholding on time.

KINGSTON, Jamaica—Attend any outdoor sound system party in Kingston and you are guaranteed to experience at least two things: loud, bass-thumping reggae and dancehall blasting from a gigantic stack of speakers, and clouds of marijuana smoke rising over the crowd. Like peanuts at a baseball game, the two go hand-in-hand, and it’s been that way for almost five decades.

While not everyone at the party is smoking, marijuana is usually easy to come by if you’re looking. Just stop one of the vendors who will be periodically walking through the crowd with 12-inch stalks, selling buds from the dried plant for $100 Jamaican dollars ($1).

Advertisement

More lawmakers are toking — er, signing — up their names to become co-sponsors of a bill that would legalize marijuana for medicinal purposes at a federal level.

Veteran Democrat Barbara Boxer, the longest-serving woman in Congress, added her name to a list of co-sponsors of the bill, according to Roll Call.

Medical marijuana is going to cost us

And so the levee breaks.

The man to break it is called Jonathan Zaid.

A student at the University of Waterloo. An earnest, likeable young man with an almost unbelievable story to tell.

Although we always knew the person who would break the medicinal-marijuana-insurance-levee would have those qualities.

Earnest. Likable. An almost unbelievable story to tell.

Jonathan Zaid was diagnosed at the age of 14 with New Daily Persistent Headache (NDPH), a medical condition so poorly understood doctors debate everything from forms of treatment to whether it should be viewed as a syndrome or diagnosis.

The legislative season is in full swing across the country, and pot is hot -- especially in New England

And we’re not even talking about medical marijuana or decriminalization bills, we’re talking about outright legalization bills.

Marijuana buds are often two to three times as potent as they were 30 years ago.

More than a year into Colorado's experiment legalizing marijuana, labs testing the plants are able for the first time to take stock of the drug's potency and contaminants—and openly paint a picture of what's in today's weed. At the 249th National Meeting & Exposition of the American Chemical Society (ACS), one such lab will present trends—and some surprises—that its preliminary testing has revealed about the marijuana now on the market.